2022
DOI: 10.3389/fphar.2022.1003264
|View full text |Cite
|
Sign up to set email alerts
|

In Vivo and in vitro antitumor activity of tomatine in hepatocellular carcinoma

Abstract: Background: There is abundant ethnopharmacological evidence the uses of regarding Solanum species as antitumor and anticancer agents. Glycoalkaloids are among the molecules with antiproliferative activity reported in these species.Purpose: To evaluate the anticancer effect of the Solanum glycoalkaloid tomatine in hepatocellular carcinoma (HCC) in vitro (HepG2 cells) and in vivo models.Methods: The resazurin reduction assay was performed to detect the effect of tomatine on cell viability in human HepG2 cell lin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 64 publications
1
5
0
Order By: Relevance
“…Caspase 3 is absent in MCF-7, but capase 7 is readily activated [ 24 ]. In accordance with our results, caspase 3 was recently shown to be weakly expressed in intact hepatocellular carcinoma HepG2 cells [ 67 ], supporting earlier findings documenting the lower expression of caspase 1 and caspase 3 in hepatocellular carcinoma tissue compared to nontumor cells [ 68 , 69 ]. Conversely, caspase 3 was found to be overexpressed in HepG2 and absent in colon carcinoma cell lines [ 70 ].…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…Caspase 3 is absent in MCF-7, but capase 7 is readily activated [ 24 ]. In accordance with our results, caspase 3 was recently shown to be weakly expressed in intact hepatocellular carcinoma HepG2 cells [ 67 ], supporting earlier findings documenting the lower expression of caspase 1 and caspase 3 in hepatocellular carcinoma tissue compared to nontumor cells [ 68 , 69 ]. Conversely, caspase 3 was found to be overexpressed in HepG2 and absent in colon carcinoma cell lines [ 70 ].…”
Section: Discussionsupporting
confidence: 93%
“…Caspase 3/7 activity in 5 μg proteins of intact and ARA-treated cell homogenate extracts was evaluated using the Caspase-Glo 3/7 Assay of Promega, following the manufacturer’s instructions, whereby released luminescence minus background values is proportional to the amount of caspase activity present [ 19 , 67 , 89 , 90 ].…”
Section: Methodsmentioning
confidence: 99%
“…The mechanism of its anti-tumoral activity seems to include the disruption of tumor cell membranes, cell cycle arrest, and the inhibition of DNA replication [115]. In human hepatocarcinoma cells (HepG2), α-tomatine (30 µM) triggers apoptosis via the stimulation of caspases 3 and 7, two potent pro-apoptotic factors, as well as the inhibition of the expression of the anti-apoptotic protein Bcl-2 [93,116].…”
Section: Anti-tumoral Effectsmentioning
confidence: 99%
“…In the context of cancer, tomatine has shown promising results in inhibiting cell invasion and melanoma-dependent angiogenesis by reducing the release of vascular endothelial growth factor (VEGF) and interfering with tumor-stimulating effects on capillary tube formation, thus exerting suppressive effects on melanoma progression [29]. Moreover, tomatine has exhibited potent anti-inflammatory and anticancer effects both in vitro and in vivo, particularly against androgen-independent prostate cancer [15,42], hepatocellular carcinoma [43], non-small cell lung cancer [44], breast [45], and ovarian cancer [46].…”
Section: Immunomodulatory Propertiesmentioning
confidence: 99%